EDGE PharmaTech
ActiveSummary
EDGE PharmaTech has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €7,813 and a net result of €62,813. Equity is shrinking by about 27% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2026. Its solvency ranks better than 14% of 11,632 sector peers (NACE 71, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Directors
Directors
No directors read yet: 1 of 3 Gazette acts processed. See the directors and other office holders in the KBO →
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.